Faculty of Medicine, University of NSW, Kensington, NSW, Australia.
Department of Radiology, I-MED Radiology Network, Ground Floor, 527-533 Kingsway, Miranda, 2228, Australia.
BMC Urol. 2022 Sep 3;22(1):141. doi: 10.1186/s12894-022-01082-9.
To develop a system for multi-parametric MRI to differentiate benign from malignant solid renal masses and assess its accuracy compared to the gold standard of histopathological diagnosis.
This is a retrospective analysis of patients who underwent 3 Tesla mpMRI for further assessment of small renal tumours with specific scanning and reporting protocol incorporating T2 HASTE signal intensity, contrast enhancement ratios, apparent diffusion coefficient and presence of microscopic/macroscopic fat. All MRIs were reported prior to comparison with histopathologic diagnosis and a reporting scheme was developed. 2 × 2 contingency table analysis (sensitivity, specificity, positive predictive value (PPV) and negative predictive value (NPV)), Fisher Exact test were used to assess the association between suspicion of malignancy on mpMRI and histopathology, and descriptive statistics were performed.
67 patients were included over a 5-year period with a total of 75 renal masses. 70 masses were confirmed on histopathology (five had pathognomonic findings for angiomyolipomas; biopsy was therefore considered unethical, so these were included without histopathology). Three patients were excluded due to a non-diagnostic result, non-standardised imaging and one found to be an organising haematoma rather than a mass. Therefore 72 cases were included in analysis (in 64 patients, with seven patients having multiple tumours). Unless otherwise specified, all further statistics refer to individual tumours rather than patients. 52 (72.2%) were deemed 'suspicious or malignant' and 20 (27.8%) were deemed 'benign' on mpMRI. 51 cases (70.8%) had renal cell carcinoma confirmed. The sensitivity, NPV, specificity and PPV for MRI for detecting malignancy were 96.1%, 90%, 85.7% and 94.2% respectively, Fisher's exact test demonstrated p < 0.0001 for the association between suspicion of malignancy on MRI and histopathology.
The de Silva St George classification scheme performed well in differentiating benign from malignant solid renal masses, and may be useful in predicting the likelihood of malignancy to determine the need for biopsy/excision. Further validation is required before this reporting system can be recommended for clinical use.
开发一种多参数 MRI 系统,以区分良性和恶性实体性肾肿瘤,并评估其与组织病理学诊断金标准相比的准确性。
这是一项对接受 3T 磁共振成像(mpMRI)进一步评估小肾肿瘤的患者进行的回顾性分析,该研究采用了特定的扫描和报告方案,包括 T2 HASTE 信号强度、对比增强比、表观扩散系数以及微观/宏观脂肪的存在。所有 MRI 均在与组织病理学诊断进行比较之前进行报告,并制定了报告方案。采用 2×2 列联表分析(敏感性、特异性、阳性预测值(PPV)和阴性预测值(NPV))、Fisher 精确检验评估 mpMRI 对恶性肿瘤的怀疑与组织病理学之间的关联,并进行描述性统计分析。
在 5 年期间纳入了 67 例患者,共 75 个肾肿瘤。70 个肿瘤在组织病理学上得到证实(5 个肿瘤具有血管平滑肌脂肪瘤的特征性表现;因此,活检被认为不道德,因此未进行组织病理学检查)。由于非诊断性结果、非标准化成像以及 1 例被发现为组织血肿而非肿瘤,有 3 例被排除在外。因此,共有 72 例病例纳入分析(在 64 例患者中,7 例患者有多个肿瘤)。除非另有说明,所有进一步的统计数据均指单个肿瘤而非患者。在 mpMRI 上,52 例(72.2%)被认为“可疑或恶性”,20 例(27.8%)被认为“良性”。51 例(70.8%)被证实为肾细胞癌。MRI 检测恶性肿瘤的敏感性、NPV、特异性和 PPV 分别为 96.1%、90%、85.7%和 94.2%,Fisher 精确检验表明 MRI 上对恶性肿瘤的怀疑与组织病理学之间存在显著关联(p<0.0001)。
De Silva St George 分类方案在区分良性和恶性实体性肾肿瘤方面表现良好,可能有助于预测恶性肿瘤的可能性,以确定是否需要活检/切除。在该报告系统可用于临床应用之前,需要进一步验证。